Agonist‐induced desensitisation of β 3 ‐adrenoceptors: Where, when, and how?
نویسندگان
چکیده
منابع مشابه
The cardiac β-adrenoceptors: Where and why?
The family of G-protein-coupled heptahelical receptors are widely distributed in the human body. Of special clinical importance are β-adrenoceptors, which mediate the effects of the sympathetic nervous system. In the heart, they induce, at least to a large extent, the inotropic effects of catecholamines. They confer signals from their ligands to the cell, and this signal transduction process cl...
متن کاملI-11: Cryopreservation and Utilization of Ovarian Tissue: When, Where and How?
In women, around 10% of cancers occur in those younger than 45 years old. Although aggressive chemotherapy/radiotherapy and bone marrow transplantation can cure more than 90% of girls and young women affected by disorders requiring such treatment, the ovaries are very sensitive to cytotoxic drugs, especially to alkylating agents. Therefore, these treatments can result in premature ovarian failu...
متن کامل[Noninvasive ventilation: when, how and where?].
Acute respiratory failure (ARF) of any origin is commonly seen in the Intensive Care Unit (ICU). When clinical improvement of ARF is not achieved with the usual medical treatment, tracheal intubation and invasive mechanical ventilation (MV) prove necessary--a situation which in turn implies a significant increase in morbidity--mortality. In the late 1990s, the need to avoid the complications of...
متن کاملSpeciation: Why, how, where and when?
Species are one of the few fundamental units in biology. Yet, study of how they form has had an erratic history. Despite the title of his book, Darwin gave the process of speciation little attention in the 'Origin of Species' — even though his earlier notebooks show that he thought deeply about many issues that are still current. (Darwin's apparent neglect of speciation may have been due to his...
متن کاملContinuous Insulin Infusion: When, Where, and How?
Inpatient Glycemic Targets After publication of the initial van den Berghe trial in surgical intensive care patients,1 several professional organizations published guidelines supporting near-normal glycemic targets.8,9 Subsequent trials documented an increased risk for hypoglycemia with tight glycemic control, suggesting that more modest glycemic targets may be optimal.10–13 The Normoglycemia i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Pharmacology
سال: 2019
ISSN: 0007-1188,1476-5381
DOI: 10.1111/bph.14633